Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 41
Titolo Data di pubblicazione Autori File
Beyond first-line immunotherapy: Potential therapeutic strategies based on different pattern progressions: Oligo and systemic progression 1-gen-2021 Prelaj A. +
Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake 1-gen-2021 Prelaj A. +
Cell-free DNA from cerebrospinal fluid can be used to detect the EGFR mutation status of lung adenocarcinoma patients with central nervous system metastasis 1-gen-2021 Prelaj A. +
Evaluation of Drug-Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors 1-gen-2021 Prelaj, Arsela +
Exploring the role of respiratory microbiome in lung cancer: A systematic review 1-gen-2021 Prelaj, Arsela +
Successful treatment of triple EGFR mutation T785A/L861Q/H297_E298 with afatinib 1-gen-2021 Prelaj, Arsela +
Carcinomatosis under control by osimertinib in EGFR and TP53 mutated lung adenocarcinoma 1-gen-2021 Prelaj, Arsela +
Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations 1-gen-2021 Prelaj, Arsela +
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer 1-gen-2022 Prelaj, Arsela +
Prognostic scores including peripheral blood-derived inflammatory indices in patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitors 1-gen-2022 Prelaj, Arsela +
Systemic lupus erythematosus reactivation after chemoimmunotherapy in preexisting autoimmune disease 1-gen-2022 Prelaj, Arsela +
Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients 1-gen-2022 Prelaj, ArselaMiskovic, VanjaPesenti, MattiaMazzeo, LauraMarinacci, RobertoManglaviti, SaraRestelli, MarcelloTrovo, FrancescoPedrocchi, Alessandra Laura Giulia +
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy 1-gen-2022 Prelaj, ArselaRestelli, MarcelloPedrocchi, Alessandra Laura GiuliaTrovo', Francesco +
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology 1-gen-2022 Prelaj, Arsela +
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy 1-gen-2022 Prelaj, Arsela +
Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation 1-gen-2022 Prelaj, ArselaManglaviti, Sara +
178P Explainable radiomics, machine and deep learning models to predict immune-checkpoint inhibitor treatment efficacy in advanced non-small cell lung cancer patients 1-gen-2023 Provenzano, L.Favali, M.Mazzeo, L.Trovò, F.Pedrocchi, A.Miskovic, V.Prelaj, A. +
MetaLung: Towards a Secure Architecture for Lung Cancer Patient Care on the Metaverse 1-gen-2023 Ferrarin, AlbertoTrovo, FrancescoMiskovic, VanjaPrelaj, Arsela +
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research 1-gen-2023 Prelaj, ArselaProvenzano, LeonardoMazzeo, LauraManglaviti, SaraAmbrosini, PaoloPedrocchi, Alessandra Laura GiuliaMiskovic, Vanja +
The EU-funded I3LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy 1-gen-2023 Prelaj, ArselaTrovo', FrancescoPedrocchi, Alessandra Laura GiuliaRestelli, MarcelloAmbrosini, EmiliaNuara, AlessandroMazzeo, Laura +
Mostrati risultati da 21 a 40 di 41
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile